SWOG clinical trial number
SWOG-8952 (INT-0111) (CALGB-8952) (EST-5489)
Treatment of Advanced Hodgkin's Disease - A Randomized Phase III Study Comparing ABVD vs. MOPP/ABV Hybrid
Closed
Phase
Published
Abbreviated Title
Treatment of Advanced Hodgkin's Disease - A Randomized Phase III Study Comparing ABVD vs. MOPP/ABV Hybrid
Activated
03/01/1990
Closed
11/10/1995
Research committees
Lymphoma
Publication Information Expand/Collapse
2003
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an Intergroup trial
1997
MOPP/ABV versus ABVD for advanced Hodgkin's disease - a preliminary report of CALGB 8952 (with SWOG, ECOG, NCIC).
Other Clinical Trials
SWOG Clinical Trial Number
S2308
Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma
Research Committee(s)
Lymphoma
Activated
08/01/2024
Accrual
0%
Open
Phase
SWOG Clinical Trial Number
S2207
Randomized Phase II Study of the Addition of Targeted Therapeutic Agents to Tafasitamab-Based Therapy in Non-Transplant-Eligible Patients with Relapse/Refractory Large B-Cell Lymphoma
Research Committee(s)
Lymphoma
Activated
06/30/2023
Accrual
10%
Open
Phase
SWOG Clinical Trial Number
CTSU/AHOD2131
A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
Research Committee(s)
Lymphoma
Immunomolecular Therapeutics
Activated
04/28/2023
Open
Phase